Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.

Koehler P, Mellinghoff SC, Lagrou K, Alanio A, Arenz D, Hoenigl M, Koehler FC, Lass-Flörl C, Meis JF, Richardson M, Cornely OA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1704-1712. doi: 10.1093/jac/dkz051.

PMID:
30770712
2.

EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis.

Cornely OA, Koehler P, Arenz D, C Mellinghoff S.

Mycoses. 2018 Nov;61(11):833-836. doi: 10.1111/myc.12820. Epub 2018 Jul 13.

PMID:
29944740
3.

Management of candidaemia with reference to the European confederation of medical mycology quality indicators.

Nemer S, Imtiaz T, Varikkara M, Collier A, Bal AM.

Infect Dis (Lond). 2019 Jul;51(7):527-533. doi: 10.1080/23744235.2019.1606436. Epub 2019 May 11.

PMID:
31081411
4.

EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.

Mellinghoff SC, Hoenigl M, Koehler P, Kumar A, Lagrou K, Lass-Flörl C, Meis JF, Menon V, Rautemaa-Richardson R, Cornely OA.

Mycoses. 2018 May;61(5):326-330. doi: 10.1111/myc.12746. Epub 2018 Feb 20.

PMID:
29325218
5.

EQUAL Cryptococcus Score 2018: A European Confederation of Medical Mycology Score Derived From Current Guidelines to Measure QUALity of Clinical Cryptococcosis Management.

Spec A, Mejia-Chew C, Powderly WG, Cornely OA.

Open Forum Infect Dis. 2018 Nov 12;5(11):ofy299. doi: 10.1093/ofid/ofy299. eCollection 2018 Nov. Review.

6.

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013.

Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Flörl C, Lortholary O, Meis JF, Meletiadis J, Muñoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G; European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group; European Confederation of Medical Mycology.

Clin Microbiol Infect. 2014 Apr;20 Suppl 3:5-26. doi: 10.1111/1469-0691.12371.

7.

Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.

Pana ZD, Seidel D, Skiada A, Groll AH, Petrikkos G, Cornely OA, Roilides E; Collaborators of Zygomyco.net and/or FungiScope™ Registries*.

BMC Infect Dis. 2016 Nov 10;16(1):667.

8.

The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis).

Lortholary O, Fernández-Ruiz M, Perfect JR.

J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii31-ii36.

PMID:
27880667
9.

The surgical management of rhinocerebral mucormycosis.

Abu El-Naaj I, Leiser Y, Wolff A, Peled M.

J Craniomaxillofac Surg. 2013 Jun;41(4):291-5. doi: 10.1016/j.jcms.2012.03.019. Epub 2012 Oct 9.

PMID:
23058177
10.

Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship.

Mellinghoff SC, Hartmann P, Cornely FB, Knauth L, Köhler F, Köhler P, Krause C, Kronenberg C, Kranz SL, Menon V, Müller H, Naendrup JH, Pützfeld S, Ronge A, Rutz J, Seidel D, Wisplinghoff H, Cornely OA.

Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1563-1571. doi: 10.1007/s10096-018-3285-8. Epub 2018 Jun 13.

PMID:
29948362
11.

Mucormycosis: New Developments into a Persistently Devastating Infection.

Danion F, Aguilar C, Catherinot E, Alanio A, DeWolf S, Lortholary O, Lanternier F.

Semin Respir Crit Care Med. 2015 Oct;36(5):692-705. doi: 10.1055/s-0035-1562896. Epub 2015 Sep 23. Review.

PMID:
26398536
12.

Delaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis.

Jeong SJ, Lee JU, Song YG, Lee KH, Lee MJ.

Mycoses. 2015 Dec;58(12):746-52. doi: 10.1111/myc.12428. Erratum in: Mycoses. 2016 Mar;59(3):194.

PMID:
26565066
13.

Pulmonary Mucormycosis (Zygomycosis) Presenting as an Infective Exacerbation of Chronic Obstructive Pulmonary Disease.

Koushiappi E, Porfyridis I, Karagiannis C, Adamide T, Georgiou A.

Eur J Case Rep Intern Med. 2018 Dec 27;5(12):000995. doi: 10.12890/2018_000995. eCollection 2018.

14.

Development of new strategies for early diagnosis of mucormycosis from bench to bedside.

Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A, Zaoutis T, Groll A, Lortholary O, Kontoyiannis DP, Petrikkos G.

Mycoses. 2014 Dec;57 Suppl 3:2-7. doi: 10.1111/myc.12249.

15.

Risk factors for early mortality in haematological malignancy patients with pulmonary mucormycosis.

Lewis RE, Georgiadou SP, Sampsonas F, Chamilos G, Kontoyiannis DP.

Mycoses. 2014 Jan;57(1):49-55. doi: 10.1111/myc.12101. Epub 2013 Jun 12.

16.

Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto).

Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, Cenacchi A, Pacilli L, Fabbiano F, Del Favero A.

Br J Haematol. 1997 Nov;99(2):331-6.

PMID:
9375750
17.

Focus on invasive mucormycosis in paediatric haematology oncology patients: a series of 11 cases.

Phulpin-Weibel A, Rivier A, Leblanc T, Bertrand Y, Chastagner P.

Mycoses. 2013 May;56(3):236-40. doi: 10.1111/myc.12010. Epub 2012 Oct 1.

PMID:
23020159
18.

Improving outcome of fungal diseases - Guiding experts and patients towards excellence.

Cornely OA, Lass-Flörl C, Lagrou K, Arsic-Arsenijevic V, Hoenigl M.

Mycoses. 2017 Jul;60(7):420-425. doi: 10.1111/myc.12628. Epub 2017 May 12. Review.

20.

Correlation of fungal cultures from non-sterile sites and Galactomannan assay with the diagnosis of aspergillosis and mucormycosis based on sterile culture results and histopathologic findings.

Kim T, Jung J, Song JS, Sung H, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH, Ja Cho K.

Infect Dis (Lond). 2019 May;51(5):373-376. doi: 10.1080/23744235.2019.1590632. Epub 2019 Apr 2.

PMID:
30938208

Supplemental Content

Support Center